Inhibitors targeting Stat3 or IL-6 could significantly attenuate the pneumonia induced by AC, expanding our understanding of angiostrongyliasis cantonensis and providing effective candidate targets for intervention in AC-induced pneumonia. The gene discussed is STAT3; the disease is pneumonia.